Our Products

Pharmaceutical intermediates, specialty chemicals, and custom synthesis for global markets

R-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid (RCMH) CORE PRODUCT

Key chiral intermediate for the commercial synthesis of the anticonvulsant and neuropathic pain API Pregabalin.

Purity ≥99.0% (Chiral ee ≥99.5%)
Capacity [CAPACITY TO BE CONFIRMED]
Appearance White Crystalline Powder
Melting Point 132 - 136 °C
KEY APPLICATIONS

Pregabalin (API) Commercial Synthesis, Anticonvulsant & Neuropathic Pain Formulations, Chiral Asymmetric Synthesis

(±)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid (CMH) KEY INTERMEDIATE

Primary racemic intermediate widely used in multi-step chemical synthesis of Pregabalin.

Purity 98.0% - 99.0%
Capacity [CAPACITY TO BE CONFIRMED]
Appearance White Crystalline Powder
Melting Point 106 - 108 °C
KEY APPLICATIONS

Pregabalin API Precursor Synthesis, Racemic Chemical Processing, Anticonvulsant & Neurological Medication Production

Bis(2-Chloroethyl)Amine Hydrochloride (Bis Salt) API INTERMEDIATE

Essential API intermediate for oncology (Cyclophosphamide, Ifosfamide), antifungal (Itraconazole, Ketoconazole), and CNS (Aripiprazole) drugs.

Purity 98.0% - 99.0%
Capacity [CAPACITY TO BE CONFIRMED]
Appearance White Crystalline Powder
Melting Point 210 - 217 °C
KEY APPLICATIONS

Aripiprazole & Trazodone (CNS / Antipsychotics), Cyclophosphamide & Ifosfamide (Oncology APIs), Itraconazole & Ketoconazole (Antifungals)

2,4-Dichloroacetophenone (DCAP) API INTERMEDIATE

2,4-Dichloroacetophenone (DCAP)

DCAP · CAS 2234-16-4

Key API intermediate for the commercial synthesis of broad-spectrum antifungal agents including Ketoconazole, Itraconazole, and Miconazole.

Purity ≥98.5%
Capacity [CAPACITY TO BE CONFIRMED]
Appearance Clear to light yellow liquid / low-melting solid
Melting Point 33 - 34 °C
KEY APPLICATIONS

Ketoconazole & Itraconazole API Synthesis, Miconazole & Antifungal Therapeutics, Propiconazole, Azaconazole & Agrochemical Synthesis

Trans-4-Aminocyclohexanol (4-TACH) PHARMA INTERMEDIATE

Trans-4-Aminocyclohexanol (4-TACH)

4-TACH · CAS 27489-62-9

Key pharmaceutical intermediate used in the synthesis of Ambroxol, a widely used mucolytic API for respiratory therapy.

Purity [TO BE CONFIRMED — verify assay spec with technical team]
Capacity [TO BE CONFIRMED]
Appearance White to off-white crystalline powder
Melting Point 109 - 113 °C
KEY APPLICATIONS

Ambroxol API Synthesis (Mucolytic / Respiratory), Advanced Pharmaceutical Intermediate Synthesis, Chemical Building Block for API Manufacturing

2,4-Difluoro-alpha-(1H-1,2,4-triazolyl)acetophenone (DFTA) PHARMA INTERMEDIATE

Critical pharmaceutical intermediate for the commercial synthesis of Fluconazole, a widely prescribed broad-spectrum antifungal API.

Purity [TO BE CONFIRMED — verify assay spec with technical team]
Capacity [TO BE CONFIRMED]
Appearance White to pale yellow powder
Melting Point 104 - 106 °C
KEY APPLICATIONS

Fluconazole API Synthesis (Broad-Spectrum Antifungal), Azole Antifungal Intermediate Synthesis, Advanced Pharmaceutical Building Block

Quality Assurance: All chemical and pharmaceutical products are supplied with complete analytical documentation including Certificate of Analysis (CoA), Method of Analysis (MoA), Route of Synthesis (ROS), and Material Safety Data Sheet (MSDS). Custom specifications and bulk scale syntheses available upon request.

Custom Requirements?

Don't See What You Need?

We offer custom contract synthesis from pilot scale to commercial production. Contact our technical and export team for specific molecular requirements.

Send Custom Enquiry
Chat with us